| Date Filed | Type | Description |
| 10/03/2023 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Paid exercise price by delivering 3,444 shares
@ $0.6199, valued at
$2.1k
Exercised 9,956 restricted stock units
@ $0 |
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Paid exercise price by delivering 1,842 shares
@ $1.39, valued at
$2.6k
Exercised 5,067 restricted stock units
@ $0 |
|
| 02/03/2023 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Granted 102,688 options
@ $3.16, valued at
$324.5k
Granted 78,234 restricted stock units
@ $0 |
|
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Paid exercise price by delivering 500 shares
@ $2.55, valued at
$1.3k
Exercised 1,221 restricted stock units
@ $0 |
|
| 02/04/2022 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Granted 81,395 options
@ $2.8, valued at
$227.9k
Granted 61,532 restricted stock units
@ $0 |
|
| 01/04/2022 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Paid exercise price by delivering 505 shares
@ $3.21, valued at
$1.6k
Exercised 1,231 restricted stock units
@ $0 |
|
| 01/04/2022 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Paid exercise price by delivering 501 shares
@ $3.21, valued at
$1.6k
Exercised 1,221 restricted stock units
@ $0 |
|
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Granted 27,427 options
@ $6.81, valued at
$186.8k
Granted 19,536 restricted stock units
@ $0 |
|
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2018 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 09/27/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/27/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/31/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/29/2012 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 49 shares
@ $5, valued at
$245
Exercised 49 options to buy
@ $2.57, valued at
$125.9 |
|
| 06/18/2012 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 3,559 shares
@ $5.7681, valued at
$20.5k
Exercised 3,559 options to buy
@ $2.57, valued at
$9.1k
|
|
| 04/17/2012 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 3,559 shares
@ $6.05, valued at
$21.5k
Exercised 3,559 options to buy
@ $2.57, valued at
$9.1k
|
|
| 02/16/2012 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 3,559 shares
@ $7.74, valued at
$27.5k
Exercised 3,559 options to buy
@ $2.57, valued at
$9.1k
|
|
| 09/28/2011 |
4/A
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 37,872 options to buy
@ $5.13, valued at
$194.3k
Granted 113,616 options to buy
@ $5.13, valued at
$582.9k
|
|
| 09/26/2011 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 37,872 options to buy
@ $5.13, valued at
$194.3k
Granted 113,616 options to buy
@ $5.13, valued at
$582.9k
|
|
| 02/18/2011 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
| 11/23/2010 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 113,616 options to buy
@ $3.54, valued at
$402.2k
|
|
| 10/13/2010 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 56,808 options to buy
@ $2.97, valued at
$168.7k
|
|
| 03/11/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/01/2009 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on RAPTOR PHARMACEUTICALS CORP. |
| 10/01/2009 |
4
| Tsuchimoto Kim R (CFO) has filed a Form 4 on Raptor Pharmaceutical Corp |